Search

Your search keyword '"Patnick, J"' showing total 464 results
Start Over Author "Patnick, J"
464 results on '"Patnick, J"'

51. Mammographic surveillance in women younger than 50 years who have a family history of breast cancer: tumour characteristics and projected effect on mortality in the prospective, single-arm, FH01 study

Author

Duffy, S, Mackay, J, Thomas, S, Anderson, E, Evans, D, Fielder, H, Fox, R, Gray, J, Gui, G, Macmillan, D, Moss, S, Rogers, C, Sainsbury, R, Sibbering, M, Boggis, C, Burn, J, Cuzick, J, Haward, B, Howell, A, Mansel, R, Cork, H, Robertson, J, Patnick, J, Pharoah, P, and Robinson, A

Published
2016

52. Do women know that the risk of breast cancer increases with age?

Author

Moser, K, Patnick, J, and Beral, V

Abstract

It is important that women know that the risk of breast cancer increases with age. Women's knowledge of the increased risk will help to inform their health-seeking behaviour. This study shows that over 50% of women wrongly believe that the risk does not vary with age. Only 1% are correctly informed, believing that the oldest group of women are at the greatest risk of breast cancer. Those working in primary care need to be aware of this lack of knowledge when patients consult.

Published
2016

53. Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient data for 8135 women in 22 randomised trials

Author

Mcgale, P., Taylor, C., Correa, C., Cutter, D., Duane, F., Ewertz, M., Gray, R., Mannu, G., Peto, R., Whelan, T., Wang, Y., Wang, Z., Darby, S., Albain, K., Anderson, S., Arriagada, R., Barlow, W., Bergh, J., Bergsten Nordström, E., Bliss, J., Burrett, J. A., Buyse, M., Cameron, D., Carrasco, E., Clarke, M., Coleman, R., Coates, A., Collins, R., Costantino, J., Cuzick, J., Davidson, N., Davies, C., Davies, K., Delmestri, A., Di Leo, A., Dowsett, M., Elphinstone, P., Evans, V., Forbes, J., Gelber, R., Gettins, L., Geyer, C., Gianni, L., Gnant, M., Goldhirsch, A., Godwin, J., Gregory, C., Hayes, D., Hill, C., Ingle, J., Jakesz, R., James, S., Janni, W., Kaufmann, M., Kerr, A., Liu, H., Mackinnon, E., Martín, M., Mchugh, T., Morris, P., Norton, L., Ohashi, Y., Paik, S., Pan, H. C., Perez, E., Piccart, M., Pierce, L., Pritchard, K., Pruneri, G., Raina, V., Ravdin, P., Robertson, J., Rutgers, E., Shao, Y. F., Sparano, J., Swain, S., Valagussa, P., Viale, G., Von Minckwitz, G., Winer, E., Wiang, X., Wood, Abe O, W., Abe, R, Enomoto, K, Kikuchi, K, Koyama, H, Masuda, H, Nomura, Y, Ohashi, Y, Sakai, K, Sugimachi, K, Toi, M, Tominaga, T, Uchino, J, Yoshida, M, Haybittle, Jl, Leonard, Cf, Calais, G, Geraud, P, Collett, V, Davies, C, Delmestri, A, Sayer, J, Harvey, Vj, Holdaway, Im, Kay, Rg, Mason, Bh, Forbes, Jf, Wilcken, N, Bartsch, R, Dubsky, P, Fesl, C, Fohler, H, Gnant, M, Greil, R, Jakesz, R, Lang, A, Luschin-Ebengreuth, G, Marth, C, Mlineritsch, B, Samonigg, H, Singer, Cf, Steger, Gg, Stöger, H, Canney, P, Yosef, Hm, Focan, C, Peek, U, Oates, Gd, Powell, J, Durand, M, Mauriac, L, Di Leo, A, Dolci, S, Larsimont, D, Nogaret, Jm, Philippson, C, Piccart, Mj, Masood, Mb, Parker, D, Price, Jj, Lindsay, Ma, Mackey, J, Martin, M, Hupperets, Ps, Bates, T, Blamey, Rw, Chetty, U, Ellis, Io, Mallon, E, Morgan, Da, Patnick, J, Pinder, S, Olivotto, I, Ragaz, J, Berry, D, Broadwater, G, Cirrincione, C, Muss, H, Norton, L, Weiss, Rb, Abu-Zahra, Ht, Portnoj, Sm, Bowden, S, Brookes, C, Dunn, J, Fernando, I, Lee, M, Poole, C, Rea, D, Spooner, D, Barrett-Lee, Pj, Mansel, Re, Monypenny, Ij, Gordon, Nh, Davis, Hl, Cuzick, J, Lehingue, Y, Romestaing, P, Dubois, Jb, Delozier, T, Griffon, B, Mace Lesech, J, Brain, E, de La Lande, B, Mouret-Fourme, E, Mustacchi, G, Petruzelka, L, Pribylova, O, Owen, Jr, Harbeck, N, Jänicke, F, Meisner, C, Schmitt, M, Thomssen, C, Meier, P, Shan, Y, Shao, Yf, Wang, X, Zhao, Db, Chen, Zm, Pan, Hc, Howell, A, Swindell, R, Burrett, Ja, Clarke, M, Collins, R, Correa, C, Cutter, D, Darby, S, Davies, K, Elphinstone, P, Evans, V, Gettins, L, Godwin, J, Gray, R, Gregory, C, Hermans, D, Hicks, C, James, S, Kerr, A, Liu, H, Mackinnon, E, Lay, M, Mcgale, P, Mchugh, T, Morris, P, Peto, R, Taylor, C, Wang, Y, Albano, J, de Oliveira CF, Gervásio, H, Gordilho, J, Ejlertsen, B, Jensen, Mb, Johansen, H, Mouridsen, H, Palshof, T, Gelman, Rs, Harris, Jr, Hayes, D, Henderson, C, Shapiro, Cl, Winer, E, Christiansen, P, Ewertz, M, Møller, S, Mouridsen, Ht, Trampisch, Hj, Dalesio, O, de Vries EG, Rodenhuis, S, van Tinteren, H, Comis, Rl, Davidson, Ne, Robert, N, Sledge, G, Solin, Lj, Sparano, Ja, Tormey, Dc, Wood, W, Cameron, D, Dixon, Jm, Forrest, P, Jack, W, Kunkler, I, Rossbach, J, Klijn, Jg, Treurniet-Donker, Ad, van Putten WL, Rotmensz, N, Veronesi, U, Viale, G, Bartelink, H, Bijker, N, Bogaerts, J, Cardoso, F, Cufer, T, Julien, Jp, Rutgers, E, van de Velde CJ, Cunningham, Mp, Huovinen, R, Joensuu, H, Costa, A, Bonadonna, G, Gianni, L, Valagussa, P, Goldstein, Lj, Bonneterre, J, Fargeot, P, Fumoleau, P, Kerbrat, P, Luporsi, E, Namer, M, Eiermann, W, Hilfrich, J, Jonat, W, Kaufmann, M, Kreienberg, R, Schumacher, M, Bastert, G, Rauschecker, H, Sauer, R, Sauerbrei, W, Schauer, A, Blohmer, Ju, Costa, Sd, Eidtmann, H, Gerber, B, Jackisch, C, Loibl, S, von Minckwitz, G, de Schryver, A, Vakaet, L, Belfiglio, M, Nicolucci, A, Pellegrini, F, Pirozzoli, Mc, Sacco, M, Valentini, M, Mcardle, Cs, Smith, Dc, Stallard, S, Dent, Dm, Gudgeon, Ca, Hacking, A, Murray, E, Panieri, E, Werner, Id, Carrasco, E, Segui, Ma, Galligioni, E, Lopez, M, Erazo, A, Medina, Jy, Horiguchi, J, Takei, H, Fentiman, Is, Hayward, Jl, Rubens, Rd, Skilton, D, Scheurlen, H, Sohn, Hc, Untch, M, Dafni, U, Markopoulos, C, Fountzilas, G, Mavroudis, D, Klefstrom, P, Blomqvist, C, Saarto, T, Gallen, M, Tinterri, C, Margreiter, R, de Lafontan, B, Mihura, J, Roché, H, Asselain, B, Salmon, Rj, Vilcoq, Jr, André, F, Arriagada, R, Delaloge, S, Hill, C, Koscielny, S, Michiels, S, Rubino, C, A'Hern, R, Bliss, J, Ellis, P, Kilburn, L, Yarnold, Jr, Benraadt, J, Kooi, M, van de Velde AO, van Dongen JA, Vermorken, Jb, Castiglione, M, Coates, A, Colleoni, M, Collins, J, Forbes, J, Gelber, Rd, Goldhirsch, A, Lindtner, J, Price, Kn, Regan, Mm, Rudenstam, Cm, Senn, Hj, Thuerlimann, B, Bliss, Jm, Chilvers, Ce, Coombes, Rc, Hall, E, Marty, M, Buyse, M, Possinger, K, Schmid, P, Wallwiener, D, Foster, L, George, Wd, Stewart, Hj, Stroner, P, Borovik, R, Hayat, H, Inbar, Mj, Peretz, T, Robinson, E, Bruzzi, P, Del Mastro, L, Pronzato, P, Sertoli, Mr, Venturini, M, Camerini, T, De Palo, G, Di Mauro MG, Formelli, F, Amadori, D, Martoni, A, Pannuti, F, Camisa, R, Cocconi, G, Colozza, A, Passalacqua, R, Aogi, K, Takashima, S, Abe, O, Ikeda, T, Inokuchi, K, Sawa, K, Sonoo, H, Korzeniowski, S, Skolyszewski, J, Ogawa, M, Yamashita, J, Bastiaannet, E, van de Water, W, van Nes JG, Christiaens, R, Neven, P, Paridaens, R, Van den Bogaert, W, Braun, S, Martin, P, Romain, S, Janauer, M, Seifert, M, Sevelda, P, Zielinski, Cc, Hakes, T, Hudis, Ca, Wittes, R, Giokas, G, Kondylis, D, Lissaios, B, de la Huerta, R, Sainz, Mg, Altemus, R, Camphausen, K, Cowan, K, Danforth, D, Lichter, A, Lippman, M, O'Shaughnessy, J, Pierce, Lj, Steinberg, S, Venzon, D, Zujewski, Ja, D'Amico, C, Lioce, M, Paradiso, A, Chapman, Ja, Gelmon, K, Goss, Pe, Levine, Mn, Meyer, R, Parulekar, W, Pater, Jl, Pritchard, Ki, Shepherd, Le, Tu, D, Whelan, T, Ohno, S, Anderson, S, Bass, G, Brown, A, Bryant, J, Costantino, J, Dignam, J, Fisher, B, Geyer, C, Mamounas, Ep, Paik, S, Redmond, C, Swain, S, Wickerham, L, Wolmark, N, Baum, M, Jackson, Im, Palmer, Mk, Perez, E, Ingle, Jn, Suman, Vj, Bengtsson, No, Emdin, S, Jonsson, H, Lythgoe, Jp, Kissin, M, Erikstein, B, Hannisdal, E, Jacobsen, Ab, Varhaug, Je, Gundersen, S, Hauer-Jensen, M, Høst, H, Nissen-Meyer, R, Reinertsen, K, Mitchell, Ak, Robertson, Jf, Ueo, H, Di Palma, M, Mathé, G, Misset, Jl, Levine, M, Morimoto, K, Takatsuka, Y, Crossley, E, Harris, A, Talbot, D, Taylor, M, di Blasio, B, Ivanov, V, Paltuev, R, Semiglazov, V, Brockschmidt, J, Cooper, Mr, Falkson, Ci, Dowsett, M, Makris, A, Parton, M, Pennert, K, Powles, Tj, Smith, Ie, Gazet, Jc, Browne, L, Graham, P, Corcoran, N, Businico, A, Deshpande, N, di Martino, L, Douglas, P, Lindtner, A, Notter, G, Bryant, Aj, Ewing, Gh, Firth, La, Krushen-Kosloski, Jl, Anderson, H, Killander, F, Malmström, P, Rydén, L, Arnesson, Lg, Carstensen, J, Dufmats, M, Fohlin, H, Nordenskjöld, B, Söderberg, M, Carpenter, Jt, Murray, N, Royle, Gt, Simmonds, Pd, Albain, K, Barlow, W, Crowley, J, Gralow, J, Hortobagyi, G, Livingston, R, Martino, S, Osborne, Ck, Ravdin, Pm, Adolfsson, J, Bergh, J, Bondesson, T, Celebioglu, F, Dahlberg, K, Fornander, T, Fredriksson, I, Frisell, J, Göransson, E, Iiristo, M, Johansson, U, Lenner, E, Löfgren, L, Nikolaidis, P, Perbeck, L, Rotstein, S, Sandelin, K, Skoog, L, Svane, G, af Trampe, E, Wadström, C, Janni, W, Maibach, R, Thürlimann, B, Hakama, M, Holli, K, Isola, J, Rouhento, K, Saaristo, R, Brenner, H, Hercbergs, A, Yoshimoto, M, Paterson, Ah, Fyles, A, Meakin, Jw, Panzarella, T, Bahi, J, Reid, M, Spittle, M, Bishop, H, Bundred, Nj, Forsyth, S, Pinder, Se, Sestak, I, Deutsch, Gp, Kwong, Dl, Pai, Vr, Senanayake, F, Martin, Al, Boccardo, F, Rubagotti, A, Hackshaw, A, Houghton, J, Ledermann, J, Monson, K, Tobias, Js, Carlomagno, C, De Laurentiis, M, De Placido, S, Williams, L, Broglio, K, Buzdar, Au, Hsu, L, Love, Rr, Ahlgren, J, Garmo, H, Holmberg, L, Liljegren, G, Lindman, H, Wärnberg, F, Asmar, L, Jones, Se, Gluz, O, Liedtke, C, Nitz, U, Litton, A, Wallgren, A, Karlsson, P, Linderholm, Bk, Chlebowski, Rt, Caffier, H., McGale, P, Taylor, C, Correa, C, Cutter, D, Duane, F, Ewertz, M, Gray, R, Mannu, G, Peto, R, Whelan, T, Wang, Y, Wang, Z, Darby, S, Biomedische Technologie, RS: GROW - Oncology, RS: GROW - R3 - Innovative Cancer Diagnostics & Therapy, Mcgale, P, DE LAURENTIIS, Michelino, Other departments, CCA -Cancer Center Amsterdam, and Radiotherapy

Subjects
medicine.medical_specialty, medicine.medical_treatment, Breast Neoplasms, Rate ratio, Lower risk, Systemic therapy, Statistical significance, Medicine, Humans, Mastectomy, Randomized Controlled Trials as Topic, business.industry, Articles, General Medicine, Surgery, Radiation therapy, Axilla, Neoplasm Recurrence, medicine.anatomical_structure, Local, Meta-analysis, Lymphatic Metastasis, Lymph Node Excision, Female, Neoplasm Recurrence, Local, business, Breast Neoplasm, Human
Abstract

BACKGROUND: Postmastectomy radiotherapy was shown in previous meta-analyses to reduce the risks of both recurrence and breast cancer mortality in all women with node-positive disease considered together. However, the benefit in women with only one to three positive lymph nodes is uncertain. We aimed to assess the effect of radiotherapy in these women after mastectomy and axillary dissection.METHODS: We did a meta-analysis of individual data for 8135 women randomly assigned to treatment groups during 1964-86 in 22 trials of radiotherapy to the chest wall and regional lymph nodes after mastectomy and axillary surgery versus the same surgery but no radiotherapy. Follow-up lasted 10 years for recurrence and to Jan 1, 2009, for mortality. Analyses were stratified by trial, individual follow-up year, age at entry, and pathological nodal status.FINDINGS: 3786 women had axillary dissection to at least level II and had zero, one to three, or four or more positive nodes. All were in trials in which radiotherapy included the chest wall, supraclavicular or axillary fossa (or both), and internal mammary chain. For 700 women with axillary dissection and no positive nodes, radiotherapy had no significant effect on locoregional recurrence (two-sided significance level [2p]>0·1), overall recurrence (rate ratio [RR], irradiated vs not, 1·06, 95% CI 0·76-1·48, 2p>0·1), or breast cancer mortality (RR 1·18, 95% CI 0·89-1·55, 2p>0·1). For 1314 women with axillary dissection and one to three positive nodes, radiotherapy reduced locoregional recurrence (2pINTERPRETATION: After mastectomy and axillary dissection, radiotherapy reduced both recurrence and breast cancer mortality in the women with one to three positive lymph nodes in these trials even when systemic therapy was given. For today's women, who in many countries are at lower risk of recurrence, absolute gains might be smaller but proportional gains might be larger because of more effective radiotherapy.FUNDING: Cancer Research UK, British Heart Foundation, UK Medical Research Council.

Published
2016
Full Text
View/download PDF

55. Colorectal cancer screening: a comparison of 35 initiatives in 17 countries

Author

Benson, V. S., Patnick, J., Davies, A. K., Nadel, M. R., Smith, R. A., and Atkin, W. S.

Subjects
RC0254, RC
Abstract

Although in its infancy, organized screening for colorectal cancer (CRC) in the general population is increasing at regional and national levels. Documenting and describing these initiatives is critical to identifying, sharing and promoting best practice in the delivery of CRC screening. Subsequently, the International Colorectal Cancer Screening Network (ICRCSN) was established in 2003 to promote best practice in the delivery of organized screening programs. The initial aim was to identify and document organized screening initiatives that commenced before May 2004. Each identified initiative was sent 1 questionnaire per screening modality: fecal occult blood test, flexible sigmoidoscopy or total colonoscopy. Information was collected on screening methodology, testing details and initiative status. In total, 35 organized initiatives were identified in 17 countries, including 10 routine population-based screening programs, 9 pilots and 16 research projects. Fecal occult blood tests were the most frequently used screening modality, and total colonoscopy was seldom used as a primary screening test. The eligible age for screening ranged from 40 years old to no upper limit; most initiatives included participants aged 50 to 64. Recruitment was usually done by a mailed invitation or during a visit to a family physician. In conclusion, this is the first investigation describing the delivery of CRC screening protocols to various populations. The work of the ICRCSN is enabling valuable information to be shared and a common nomenclature to be established.

Published
2016

56. Mammographic screening programmes in Europe: organization, coverage and participation

Author

Giordano L, von Karsa L, Tomatis M, Majek O, de Wolf C, Lancucki L, Hofvind S, Nyström L, Segnan N, Ponti A, Eunice Working Group, Van Hal G, Martens P, Májek O, Danes J, von Euler-Chelpin M, Aasmaa A, Anttila A, Becker N, Péntek Z, Budai A, Mádai S, Fitzpatrick P, Mooney T, Zappa M, Ventura L, Scharpantgen A, Seroczynski P, Morais A, Rodrigues V, Bento MJ, Gomes de Carvalho J, Natal C, Prieto M, Sánchez-Contador Escudero C, Zubizarreta Alberti R, Fernández Llanes SB, Ascunce N, Ederra Sanza M, Sarriugarte Irigoien G, Salas Trejo D, Ibáñez Cabanell J, Wiege M, Ohlsson G, Törnberg S, Korzeniewska M, Fracheboud J, Patnick J J, Ducarroz S, and Suonio E

Abstract

Objectives To summarize participation and coverage rates in population mammographic screening programmes for breast cancer in Europe. Methods We used the European Network for Information on Cancer (EUNICE), a web-based data warehouse (EUNICE Breast Cancer Screening Monitoring, EBCSM) for breast cancer screening, to obtain information on programme characteristics, coverage and participation from its initial application in 10 national and 16 regional programmes in 18 European countries. Results The total population targeted by the screening programme services covered in the report comprised 26.9 million women predominantly aged 50-69. Most of the collected data relates to 2005, 2006 and/or 2007. The average participation rate across all programmes was 53.4% (range 19.4-88.9% of personally invited); or 66.4% excluding Poland, a large programme that initiated personal invitations in 2007. Thirteen of the 26 programmes achieved the European Union benchmark of acceptable participation (>70%), nine achieved the desirable level (>75%). Despite considerable invitation coverage across all programmes (79.3%, range 50.9-115.2%) only 48.2% (range 28.4-92.1%) of the target population were actually screened. The overall invitation and examination coverage excluding Poland was 70.9% and 50.3%, respectively. Conclusions The results demonstrate the feasibility of European-wide screening monitoring using the EBCSM data warehouse, although further efforts to refine the system and to harmonize standards and data collection practices will be required, to fully integrate all European countries. The more than threefold difference in the examination coverage should be taken into account in the evaluation of service screening programmes.

Published
2012

57. Communicating the balance sheet in breast cancer screening

Author

Giordano, L., Cogo, C., Patnick, J., Paci, E., and Broeders, M.J.M.

Subjects
Point (typography), medicine.diagnostic_test, Process (engineering), Management science, business.industry, Health Policy, Decision Making, Public Health, Environmental and Occupational Health, Psychological intervention, Breast Neoplasms, Public relations, Audience measurement, Breast cancer screening, Good evidence, Humans, Mass Screening, Medicine, Female, Balance sheet, Moral responsibility, business, Early Detection of Cancer, Molecular epidemiology Aetiology, screening and detection [NCEBP 1]
Abstract

Item does not contain fulltext OBJECTIVE: Despite the difficulties, there is a moral responsibility to provide the public with the best estimates of benefits and harms of breast cancer screening. METHODS: In this paper we review the issues in communication of benefits and harms of medical interventions and discuss these in terms of the principles of the balance sheet proposed in this supplement. RESULTS: The balance sheet can be seen as a tool to convey estimates based on the best available evidence and addressed to a readership wider than just potential screening participants. It reflects a re-assessment of screening efficacy, showing again that screening is effective and brings more benefits than harms. It can be viewed as an opportunity to re-affirm some basic principles of good evidence-based communication. Further research is needed to improve communication strategy, to assess the impact of this communication on women's awareness and to evaluate its utility in the informed decision-making process. CONCLUSION: The balance sheet could be a starting point for a broader vision of informed decision-making in screening, which should also recognize the role played by 'non-numerical' factors on women's choice of participating in breast cancer screening.

Published
2012

58. False-positive results in mammographic screening for breast cancer in Europe: a literature review and survey of service screening programmes

Author

Hofvind S, Ponti A, Patnick J, Ascunce N, Njor S, Broeders M, Giordano L, Frigerio A, Törnberg S, EUNICE Project and Euroscreen Working Groups, Van Hal G, Martens P, Májek O, Danes J, von Euler-Chelpin M, Aasmaa A, Anttila A, Becker N, Péntek Z, Budai A, Mádai S, Fitzpatrick P, Mooney T, Zappa M, Ventura L, Scharpantgen A, Seroczynski P, Morais A, Rodrigues V, Bento MJ, Gomes de Carvalho J, Natal C, Prieto M, Sánchez-Contador Escudero C, Zubizarreta Alberti R, Fernández Llanes SB, Ederra Sanza M, Sarriugarte Irigoien G, Salas Trejo D, Ibáñez Cabanell J, Wiege M, Ohlsson G, Korzeniewska M, de Wolf C, Fracheboud J, Lancucki L, Ducarroz S, and Suonio E

Abstract

Objective To estimate the cumulative risk of a false-positive screening result in European mammographic screening programmes, and examine the rates and procedures of further assessment. Methods A literature review was conducted to identify studies of the cumulative risk of a false-positive result in European screening programmes (390,000 women). We then examined aggregate data, cross-sectional information about further assessment procedures among women with positive results in 20 mammographic screening programmes from 17 countries (1.7 million initial screens, 5.9 million subsequent screens), collected by the European Network for Information on Cancer project (EUNICE). Results The estimated cumulative risk of a false-positive screening result in women aged 50-69 undergoing 10 biennial screening tests varied from 8% to 21% in the three studies examined (pooled estimate 19.7%). The cumulative risk of an invasive procedure with benign outcome ranged from 1.8% to 6.3% (pooled estimate 2.9%). The risk of undergoing surgical intervention with benign outcome was 0.9% (one study only). From the EUNICE project, the proportions of all screening examinations in the programmes resulting in needle biopsy were 2.2% and 1.1% for initial and subsequent screens, respectively, though the rates differed between countries; the corresponding rates of surgical interventions among women without breast cancer were 0.19% and 0.07%. Conclusion The specific investigative procedures following a recall should be considered when examining the cumulative risk of a false-positive screening result. Most women with a positive screening test undergo a non-invasive assessment procedure. Only a small proportion of recalled women undergo needle biopsy, and even fewer undergo surgical intervention.

Published
2012

59. Mammographic screening programmes in Europe : organization, coverage and participation

Author

Livia, Giordano, Lawrence, von Karsa, Mariano, Tomatis, Ondrej, Majek, Chris, de Wolf, Lesz, Lancucki, Solveig, Hofvind, Lennarth, Nyström, Nereo, Segnan, Antonio, Ponti, G, Van Hal, P, Martens, O, Májek, J, Danes, M, von Euler-Chelpin, A, Aasmaa, A, Anttila, N, Becker, Z, Péntek, A, Budai, S, Mádai, P, Fitzpatrick, T, Mooney, M, Zappa, L, Ventura, A, Scharpantgen, S, Hofvind, P, Seroczynski, A, Morais, V, Rodrigues, M J, Bento, J, Gomes de Carvalho, C, Natal, M, Prieto, C, Sánchez-Contador Escudero, R, Zubizarreta Alberti, S B, Fernández Llanes, N, Ascunce, M, Ederra Sanza, G, Sarriugarte Irigoien, D, Salas Trejo, J, Ibáñez Cabanell, M, Wiege, G, Ohlsson, S, Törnberg, M, Korzeniewska, C, de Wolf, J, Fracheboud, J, Patnick J, L, Lancucki, S, Ducarroz, E, Suonio, Van Hal, Guido F., and EUNICE Working Group

Subjects
Population, MEDLINE, Breast Neoplasms, 03 medical and health sciences, Breast cancer screening, 0302 clinical medicine, Breast cancer, Environmental health, Medicine, Mammography, media_common.cataloged_instance, Humans, Mass Screening, 030212 general & internal medicine, European union, education, Mass screening, Early Detection of Cancer, media_common, education.field_of_study, Data collection, medicine.diagnostic_test, business.industry, Health Policy, Public Health, Environmental and Occupational Health, medicine.disease, 3. Good health, Europe, 030220 oncology & carcinogenesis, Female, Human medicine, business
Abstract

Objectives To summarize participation and coverage rates in population mammographic screening programmes for breast cancer in Europe. Methods We used the European Network for Information on Cancer (EUNICE), a web-based data warehouse (EUNICE Breast Cancer Screening Monitoring, EBCSM) for breast cancer screening, to obtain information on programme characteristics, coverage and participation from its initial application in 10 national and 16 regional programmes in 18 European countries. Results The total population targeted by the screening programme services covered in the report comprised 26.9 million women predominantly aged 5069. Most of the collected data relates to 2005, 2006 and/or 2007. The average participation rate across all programmes was 53.4% (range 19.488.9% of personally invited); or 66.4% excluding Poland, a large programme that initiated personal invitations in 2007. Thirteen of the 26 programmes achieved the European Union benchmark of acceptable participation (>70%), nine achieved the desirable level (>75%). Despite considerable invitation coverage across all programmes (79.3%, range 50.9115.2%) only 48.2% (range 28.492.1%) of the target population were actually screened. The overall invitation and examination coverage excluding Poland was 70.9% and 50.3%, respectively. Conclusions The results demonstrate the feasibility of European-wide screening monitoring using the EBCSM data warehouse, although further efforts to refine the system and to harmonize standards and data collection practices will be required, to fully integrate all European countries. The more than three-fold difference in the examination coverage should be taken into account in the evaluation of service screening programmes.

Published
2012

61. Clinicians' concerns about decision support interventions for patients facing breast cancer surgery options: understanding the challenge of implementing shared decision-making

Author

Caldon, L.J., Collins, K.A., Reed, M.W., Sivell, S., Austoker, J., Clements, A.M., Patnick, J., and Elwyn, G.

Subjects
Implementation Science [NCEBP 3], R1
Abstract

Contains fulltext : 95728.pdf (Publisher’s version ) (Open Access) BACKGROUND: There is interest in interventions that provide support for patients facing challenging decisions, such as the choice between mastectomy and breast conservation surgery for breast cancer. However, it is difficult to implement these interventions. One potential source of resistance is the attitudes of clinicians. OBJECTIVE: To examine specialist breast clinicians' opinions about the provision of decision support interventions (DesIs) for patients. METHODS: As part of the development of a web-based DesI (BresDex), semi-structured interviews were conducted with specialist clinicians [breast surgeons, breast care nurses (BCNs) and oncologists] from four breast units in a UK region, and speciality national opinion leaders. Interviews were recorded, transcribed and analysed using the Framework approach. RESULTS: A majority of the 24 clinicians interviewed did not have a working knowledge of DesIs and were ambivalent or sceptical. Many expressed conflicting opinions: they noted the potential benefits, but at the same time expressed reservations about information overlap, overload and about content that they considered inappropriate. Many wanted access to DesIs to be always under clinical supervision. In particular, they were uncertain as regards how DeSIs could be tailored to individual patients' needs and also accommodate clinical practice variation. BCNs were particularly concerned that DesIs might induce patient anxiety and replace their role. CONCLUSIONS: The concept of providing interventions to support patients in decision-making tasks generated concern, defensiveness and scepticism. These attitudes will be a significant barrier. Implementation efforts will need to recognize and address these issues if these interventions are to become embedded in clinical practice.

Published
2011

62. Introduction

Author

Lansdorp - Vogelaar, Iris, von Karsa, L, Segnan, N, Patnick, J, von karsa, L, and Public Health

Published
2011

63. Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomised trials

Author

EARLY BREAST CANCER TRIALISTS' COLLABORATIVE GROUP (EBCTCG), Darby, S., Mcgale, P., Correa, C., Taylor, C., Arriagada, R., Clarke, M., Cutter, D., Davies, C., Ewertz, M., Godwin, J., Gray, R., Pierce, L., Whelan, T., Wang, Y., Peto, R., Albain, K, Anderson, S, Arriagada, R, Barlow, W, Bergh, J, Bliss, J, Buyse, M, Cameron, D, Carrasco, E, Clarke, M, Correa, C, Coates, A, Collins, R, Costantino, J, Cutter, D, Cuzick, J, Darby, S, Davidson, N, Davies, C, Davies, K, Delmestri, A, Di Leo, A, Dowsett, M, Elphinstone, P, Evans, V, Ewertz, M, Gelber, R, Gettins, L, Geyer, C, Goldhirsch, A, Godwin, J, Gray, R, Gregory, C, Hayes, D, Hill, C, Ingle, J, Jakesz, R, James, S, Kaufmann, M, Kerr, A, Mackinnon, E, Mcgale, P, Mchugh, T, Norton, L, Ohashi, Y, Paik, S, Pan, Hc, Perez, E, Peto, R, Piccart, M, Pierce, L, Pritchard, K, Pruneri, G, Raina, V, Ravdin, P, Robertson, J, Rutgers, E, Shao, Yf, Swain, S, Taylor, C, Valagussa, P, Viale, G, Whelan, T, Winer, E, Wang, Y, Wood, W, Abe, O, Abe, R, Enomoto, K, Kikuchi, K, Koyama, H, Masuda, H, Nomura, Y, Sakai, K, Sugimachi, K, Toi, M, Tominaga, T, Uchino, J, Yoshida, M, Haybittle, Jl, Leonard, Cf, Calais, G, Geraud, P, Collett, V, Sayer, J, Harvey, Vj, Holdaway, Im, Kay, Rg, Mason, Bh, Forbes, Jf, Wilcken, N, Bartsch, R, Dubsky, P, Fesl, C, Fohler, H, Gnant, M, Greil, R, Lang, A, Luschin-Ebengreuth, G, Marth, C, Mlineritsch, B, Samonigg, H, Singer, Cf, Steger, Gg, Stöger, H, Canney, P, Yosef, Hm, Focan, C, Peek, U, Oates, Gd, Powell, J, Durand, M, Mauriac, L, Dolci, S, Larsimont, D, Nogaret, Jm, Philippson, C, Piccart, Mj, Masood, Mb, Parker, D, Price, Jj, Lindsay, Ma, Mackey, J, Martin, M, Hupperets, Ps, Bates, T, Blamey, Rw, Chetty, U, Ellis, Io, Mallon, E, Morgan, Da, Patnick, J, Pinder, S, Olivotto, I, Ragaz, J, Berry, D, Broadwater, G, Cirrincione, C, Muss, H, Weiss, Rb, Abu-Zahra, Ht, Portnoj, Sm, Bowden, S, Brookes, C, Dunn, J, Fernando, I, Lee, M, Poole, C, Rea, D, Spooner, D, Barrett-Lee, Pj, Mansel, Re, Monypenny, Ij, Gordon, Nh, Davis, Hl, Lehingue, Y, Romestaing, P, Dubois, Jb, Delozier, T, Griffon, B, Mace Lesec'h, J, Rambert, P, Mustacchi, G, Petruzelka, Pribylova, O, Owen, Jr, Harbeck, N, Jänicke, F, Meisner, C, Schmitt, M, Thomssen, C, Meier, P, Shan, Y, Wang, X, Zhao, Db, Chen, Zm, Howell, A, Swindell, R, Burrett, Ja, Hermans, D, Hicks, C, Lay, M, Albano, J, de Oliveira CF, Gervásio, H, Gordilho, J, Johansen, H, Mouridsen, Ht, Gelman, Rs, Harris, Jr, Henderson, C, Shapiro, Cl, Christiansen, P, Ejlertsen, B, Jensen, Mb, Møller, S, Carstensen, B, Palshof, T, Trampisch, Hj, Dalesio, O, de Vries EG, Rodenhuis, S, van Tinteren, H, Comis, Rl, Davidson, Ne, Robert, N, Sledge, G, Solin, Lj, Sparano, Ja, Tormey, Dc, Dixon, Jm, Forrest, P, Jack, W, Kunkler, I, Rossbach, J, Klijn, Jg, Treurniet-Donker, Ad, van Putten WL, Rotmensz, N, Veronesi, U, Bartelink, H, Bijker, N, Bogaerts, J, Cardoso, F, Cufer, T, Julien, Jp, van de Velde CJ, Cunningham, Mp, Huovinen, R, Joensuu, H, Costa, A, Tinterri, C, Bonadonna, G, Gianni, L, Goldstein, Lj, Bonneterre, J, Fargeot, P, Fumoleau, P, Kerbrat, P, Luporsi, E, Namer, M, Eiermann, W, Hilfrich, J, Jonat, W, Kreienberg, R, Schumacher, M, Bastert, G, Rauschecker, H, Sauer, R, Sauerbrei, W, Schauer, A, Blohmer, Ju, Costa, Sd, Eidtmann, H, Gerber, G, Jackisch, C, Loibl, S, von Minckwitz, G, de Schryver, A, Vakaet, L, Belfiglio, M, Nicolucci, A, Pellegrini, F, Pirozzoli, Mc, Sacco, M, Valentini, M, Mcardle, Cs, Smith, Dc, Stallard, S, Dent, Dm, Gudgeon, Ca, Hacking, A, Murray, E, Panieri, E, Werner, Id, Segui, Ma, Galligioni, E, Lopez, M, Erazo, A, Medina, Jy, Horiguchi, J, Takei, H, Fentiman, Is, Hayward, Jl, Rubens, Rd, Skilton, D, Scheurlen, H, Sohn, Hc, Untch, M, Dafni, U, Markopoulos, C, Dafni, D, Fountzilas, G, Mavroudis, D, Klefstrom, P, Saarto, T, Gallen, M, Margreiter, R, de Lafontan, B, Mihura, J, Roché, H, Asselain, B, Salmon, Rj, Vilcoq, Jr, Bourgier, C, Koscielny, S, Laplanche, A, Lê, Mg, Spielmann, M, A'Hern, R, Ellis, P, Kilburn, L, Yarnold, Jr, Benraadt, J, Kooi, M, van de Velde AO, van Dongen JA, Vermorken, Jb, Castiglione, M, Colleoni, M, Collins, J, Forbes, J, Gelber, Rd, Lindtner, J, Price, Kn, Regan, Mm, Rudenstam, Cm, Senn, Hj, Thuerlimann, B, Bliss, Jm, Chilvers, Ce, Coombes, Rc, Hall, E, Marty, M, Possinger, K, Schmid, P, Wallwiener, D, Foster, L, George, Wd, Stewart, Hj, Stroner, P, Borovik, R, Hayat, H, Inbar, Mj, Robinson, E, Bruzzi, P, Del Mastro, L, Pronzato, P, Sertoli, Mr, Venturini, M, Camerini, T, De Palo, G, Di Mauro MG, Formelli, F, Amadori, D, Martoni, A, Pannuti, F, Camisa, R, Cocconi, G, Colozza, A, Passalacqua, R, Aogi, K, Takashima, S, Ikeda, T, Inokuchi, K, Sawa, K, Sonoo, H, Korzeniowski, S, Skolyszewski, J, Ogawa, M, Yamashita, J, Bastiaannet, E, van de Water, W, van Nes JG, Christiaens, R, Neven, P, Paridaens, R, Van den Bogaert, W, Braun, S, Janni, W, Martin, P, Romain, S, Janauer, M, Seifert, M, Sevelda, P, Zielinski, Cc, Hakes, T, Hudis, Ca, Wittes, R, Giokas, G, Kondylis, D, Lissaios, B, de la Huerta, R, Sainz, Mg, Altemus, R, Camphausen, K, Cowan, K, Danforth, D, Lichter, A, Lippman, M, O'Shaughnessy, J, Pierce, Lj, Steinberg, S, Venzon, D, Zujewski, Ja, D'Amico, C, Lioce, M, Paradiso, A, Chapman, Ja, Gelmon, K, Goss, Pe, Levine, Mn, Meyer, R, Parulekar, W, Pater, Jl, Pritchard, Ki, Shepherd, Le, Tu, D, Ohno, S, Anderson, A, Bass, G, Brown, A, Bryant, J, Dignam, J, Fisher, B, Mamounas, Ep, Redmond, C, Wickerham, L, Wolmark, N, Baum, M, Jackson, Im, Palmer, Mk, Ingle, Jn, Suman, Vj, Bengtsson, No, Emdin, S, Jonsson, H, Lythgoe, Jp, Kissin, M, Erikstein, B, Hannisdal, E, Jacobsen, Ab, Varhaug, Je, Gundersen, S, Hauer-Jensen, M, Høst, H, Nissen-Meyer, R, Mitchell, Ak, Robertson, Jf, Ueo, H, Di Palma, M, Mathé, G, Misset, Jl, Levine, M, Morimoto, K, Takatsuka, Y, Crossley, E, Harris, A, Talbot, D, Taylor, M, Martin, Al, di Blasio, B, Ivanov, V, Paltuev, R, Semiglazov, V, Brockschmidt, J, Cooper, Mr, Falkson, Ci, Ashley, S, Makris, A, Powles, Tj, Smith, Ie, Gazet, Jc, Browne, L, Graham, P, Corcoran, N, Deshpande, N, di Martino, L, Douglas, P, Lindtner, A, Notter, G, Bryant, Aj, Ewing, Gh, Firth, La, Krushen-Kosloski, Jl, Anderson, H, Killander, F, Malmström, P, Rydén, L, Arnesson, Lg, Carstensen, J, Dufmats, M, Fohlin, H, Nordenskjöld, B, Söderberg, M, Carpenter, Jt, Murray, N, Royle, Gt, Simmonds, Pd, Crowley, J, Gralow, J, Green, S, Hortobagyi, G, Livingston, R, Martino, S, Osborne, Ck, Adolfsson, J, Bondesson, T, Celebioglu, F, Dahlberg, K, Fornander, T, Fredriksson, I, Frisell, J, Göransson, E, Iiristo, M, Johansson, U, Lenner, E, Löfgren, L, Nikolaidis, P, Perbeck, L, Rotstein, S, Sandelin, K, Skoog, L, Svane, G, af Trampe, E, Wadström, C, Maibach, R, Thürlimann, B, Hakama, M, Holli, K, Isola, J, Rouhento, K, Saaristo, R, Brenner, H, Hercbergs, A, Yoshimoto, M, Paterson, Ah, Fyles, A, Meakin, Jw, Panzarella, T, Bahi, J, Reid, M, Spittle, M, Bishop, H, Bundred, Nj, Forsyth, S, Pinder, Se, Sestak, I, Deutsch, Gp, Kwong, Dl, Pai, Vr, Senanayake, F, Boccardo, F, Rubagotti, A, Hackshaw, A, Houghton, J, Ledermann, J, Monson, K, Tobias, Js, Carlomagno, C, De Laurentiis, M, De Placido, S, Williams, L, Broglio, K, Buzdar, Au, Love, Rr, Ahlgren, J, Garmo, H, Holmberg, L, Liljegren, G, Lindman, H, Wärnberg, F, Asmar, L, Jones, Se, Gluz, O, Liedtke, C, Nitz, U, Litton, A, Wallgren, A, Karlsson, P, Linderholm, Bk, Chlebowski, Rt, Caffier, H, Mcgale, P, Correa, C, Taylor, C, Arriagada, R, Clarke, M, Cutter, D, Davies, C, Ewertz, M, Godwin, J, Gray, R, Pierce, L, Whelan, T, Wang, Y, Peto, R, Early Breast Cancer Trialists' Collaborative, Group, DE LAURENTIIS, Michelino, DE PLACIDO, Sabino, Carlomagno, Chiara, Darby, S, McGale, P, Interne Geneeskunde, RS: GROW - School for Oncology and Reproduction, Other departments, CCA -Cancer Center Amsterdam, and Radiotherapy

Subjects
Oncology, medicine.medical_specialty, Neoplasm Recurrence, Local - epidemiology, medicine.medical_treatment, Population, Breast Neoplasms, Mastectomy, Segmental, Breast cancer, breast cancer, Internal medicine, medicine, Breast-conserving surgery, Humans, education, skin and connective tissue diseases, radiotherapy, Randomized Controlled Trials as Topic, education.field_of_study, business.industry, Estrogen Antagonists - therapeutic use, Mortality rate, Age Factors, Estrogen Antagonists, General Medicine, Breast Neoplasms - mortality - therapy, medicine.disease, Surgery, Unilateral Breast Neoplasms, Radiation therapy, Clinical trial, meta-analysis, Tamoxifen, Receptors, Estrogen, Lymphatic Metastasis, Female, Radiotherapy, Adjuvant, Neoplasm Grading, Neoplasm Recurrence, Local, business, Mastectomy
Abstract

BACKGROUND: After breast-conserving surgery, radiotherapy reduces recurrence and breast cancer death, but it may do so more for some groups of women than for others. We describe the absolute magnitude of these reductions according to various prognostic and other patient characteristics, and relate the absolute reduction in 15-year risk of breast cancer death to the absolute reduction in 10-year recurrence risk. METHODS: We undertook a meta-analysis of individual patient data for 10,801 women in 17 randomised trials of radiotherapy versus no radiotherapy after breast-conserving surgery, 8337 of whom had pathologically confirmed node-negative (pN0) or node-positive (pN+) disease. FINDINGS: Overall, radiotherapy reduced the 10-year risk of any (ie, locoregional or distant) first recurrence from 35.0% to 19.3% (absolute reduction 15.7%, 95% CI 13.7-17.7, 2p/=20%), intermediate (10-19%), or lower (, link_to_OA_fulltext

Published
2011
Full Text
View/download PDF

64. European code against cancer 4th edition: 12 ways to reduce your cancer risk

Author

Schüz, J., Espina, C., Villain, P., Herrero, R., Leon, M., Minozzi, S., Romieu, I., Segnan, N., Wardle, J., Wiseman, M., Belardelli, F., Bettcher, D., Cavalli, F., Galea, G., Lenoir, G., Martin-Moreno, J., Nicula, F., Olsen, J., Patnick, J., Primic-Zakelj, M., Puska, P., Van Leeuwen, F., Wiestler, O., Zatonski, W., Guha, N., Kralikova, E., McNeill, A., Peruga, A., Anderson, A., Berrino, F., Boutron-Ruault, M., Cecchini, M., Key, T., Leitzmann, M., Norat, T., Powers, H., Scoccianti, C., Auvinen, A., de Vries, E., Erdmann, F., Greinert, R., Harrison, J., Kesminiene, A., McColl, N., Friis, S., Kogevinas, M., Saracci, R., Straif, K., Vainio, H., Almonte, M., Anttila, A., De Vuyst, H., Dillner, J., Franceschi, S., Gonzalez, P., Hall, A., Park, J., Armaroli, P., Atkin, W., Dean, P., de Koning, H., Dillner, L., Kuipers, E., Lansdorp_Vogelaar, Iris, Paci, E., Regula, J., Suonio, E., Törnberg, S., Wood, L., Gaudin, N., Frie, K., Terrasse, V., Winstanley, K., Bellisario, C., Biagioli, E., Cinquini, M., Gianola, S., Lorenzo, M., von Karsa, L., Lignini, T., Schüz, J., Espina, C., Villain, P., Herrero, R., Leon, M., Minozzi, S., Romieu, I., Segnan, N., Wardle, J., Wiseman, M., Belardelli, F., Bettcher, D., Cavalli, F., Galea, G., Lenoir, G., Martin-Moreno, J., Nicula, F., Olsen, J., Patnick, J., Primic-Zakelj, M., Puska, P., Van Leeuwen, F., Wiestler, O., Zatonski, W., Guha, N., Kralikova, E., McNeill, A., Peruga, A., Anderson, A., Berrino, F., Boutron-Ruault, M., Cecchini, M., Key, T., Leitzmann, M., Norat, T., Powers, H., Scoccianti, C., Auvinen, A., de Vries, E., Erdmann, F., Greinert, R., Harrison, J., Kesminiene, A., McColl, N., Friis, S., Kogevinas, M., Saracci, R., Straif, K., Vainio, H., Almonte, M., Anttila, A., De Vuyst, H., Dillner, J., Franceschi, S., Gonzalez, P., Hall, A., Park, J., Armaroli, P., Atkin, W., Dean, P., de Koning, H., Dillner, L., Kuipers, E., Lansdorp_Vogelaar, Iris, Paci, E., Regula, J., Suonio, E., Törnberg, S., Wood, L., Gaudin, N., Frie, K., Terrasse, V., Winstanley, K., Bellisario, C., Biagioli, E., Cinquini, M., Gianola, S., Lorenzo, M., von Karsa, L., and Lignini, T.

Abstract

This overview describes the principles of the 4th edition of the European Code against Cancer and provides an introduction to the 12 recommendations to reduce cancer risk. Among the 504.6 million inhabitants of the member states of the European Union (EU28), there are annually 2.64 million new cancer cases and 1.28 million deaths from cancer. It is estimated that this cancer burden could be reduced by up to one half if scientific knowledge on causes of cancer could be translated into successful prevention. The Code is a preventive tool aimed to reduce the cancer burden by informing people how to avoid or reduce carcinogenic exposures, adopt behaviours to reduce the cancer risk, or to participate in organised intervention programmes. The Code should also form a base to guide national health policies in cancer prevention. The 12 recommendations are: not smoking or using other tobacco products; avoiding second-hand smoke; being a healthy body weight; encouraging physical activity; having a healthy diet; limiting alcohol consumption, with not drinking alcohol being better for cancer prevention; avoiding too much exposure to ultraviolet radiation; avoiding cancer-causing agents at the workplace; reducing exposure to high levels of radon; encouraging breastfeeding; limiting the use of hormone replacement therapy; participating in organised vaccination programmes against hepatitis B for newborns and human papillomavirus for girls; and participating in organised screening programmes for bowel cancer, breast cancer, and cervical cancer.

Published
2015

65. Risk of preterm birth following surgical treatment for cervical disease: executive summary of a recent symposium

Author

Sasieni, P, primary, Castanon, A, additional, Landy, R, additional, Kyrgiou, M, additional, Kitchener, H, additional, Quigley, M, additional, Poon, LCY, additional, Shennan, A, additional, Hollingworth, A, additional, Soutter, WP, additional, Freeman‐Wang, T, additional, Peebles, D, additional, Prendiville, W, additional, and Patnick, J, additional

Published
2015
Full Text
View/download PDF

67. CT colonography standards

Author

Burling, D, Denton, E, Halligan, S, Kay, C, Maskell, G, Patnick, J, Patterson, A, Valori, R, Wiltsher, C, Lowe, A, Taylor, S, Tolan, D, Bloor, C, Muckian, J, Nightingale, J, Neri, Emanuele, Laghi, A, Stoker, J, Lefere, P, Stein, L, FRASER HILL, M, Jaffer, N, Obrien, P, Stevenson, G, Moore, H, Balasingam, A, Mendelson, R., Amsterdam Gastroenterology Endocrinology Metabolism, Cancer Center Amsterdam, and Radiology and Nuclear Medicine

Subjects
Male, medicine.medical_specialty, Virtual colonoscopy, education, Computed tomography, Computed tomographic, Patient experience, medicine, Humans, Radiology, Nuclear Medicine and imaging, Computed Tomographic Colonography, Medical physics, Referral and Consultation, Barium enema, Training curriculum, medicine.diagnostic_test, business.industry, Australia, General Medicine, United Kingdom, Europe, Practice Guidelines as Topic, Female, Clinical Competence, Clinical competence, Colorectal Neoplasms, business, Colonography, Computed Tomographic, New Zealand
Abstract

Computed tomography (CT) colonography is the established successor to the barium enema for the detection of colonic neoplasia due to superior performance and patient experience. Consequently, CT colonography is widely disseminated across Western populations and increasingly provided by both subspecialist and general radiologists alike. As a result, CT colonography is now part of the core training curriculum for radiology in the UK. However, study data shows wide performance gaps between centres and between individuals of differing experience, which is perhaps unsurprising given the complexity of the CT colonography technique and interpretation. This article summarizes the background, evolution and recommendations of the CT colonography standards document (Appendix) developed by the International CT Colonography Standards Collaboration, which included highly experienced radiologists, radiographers, gastroenterologists, and screening experts. These standards are intended to guide and support radiology teams across the world by promoting methods for improving the quality of CT colonography technique and the patient experience.

Published
2010

68. Screening for breast cancer in England: past and future

Author

Beral, V, Cush, S, Ellis, IO, Emery, J, Faulkner, K, Given-Wilson, R, Law, M, Loughlin, J, Michell, MJ, Moss, SM, Noblet, M, Patnick, J, Reed, M, Rubin, C, Toward, K, Winston, D, Austoker, J, Berrington, A, Blanks, RG, Day, NE, Day, TJ, Moller, H, Quinn, M, Wallis, MG, Wilson, ARM, and Cancer, ACB

Subjects
Adult, England, Cost-Benefit Analysis, Health Policy, Public Health, Environmental and Occupational Health, Humans, Mass Screening, Breast Neoplasms, Female, Middle Aged, State Medicine, Aged, Mammography
Abstract

• The NHS Breast Screening Programme (NHSBSP) began in 1988. It aims to invite all women aged 50–70 years for mammographic screening once every three years. The programme now screens 1.3 million women each year, about 75% of those invited, and diagnoses about 10,000 breast cancers annually. • Although some have questioned the value of screening for breast cancer, the scientific evidence demonstrates clearly that regular mammographic screening between the ages of 50 and 70 years reduces mortality from the malignancy. • Screened women are slightly more likely than unscreened women to be diagnosed with breast cancer. The cancers in screened women are smaller and are less likely to be treated with mastectomy than they would have been if diagnosed without screening. •For every 400 women screened regularly by the NHSBSP over a 10-year period, one woman fewer will die from breast cancer than would have died without screening. • The current NHSBSP saves an estimated 1400 lives each year in England. • The screening programme spends about £3000 for every year of life saved.

Published
2006

73. European guidelines for quality assurance in colorectal cancer screening and diagnosis:overview and introduction to the full supplement publication

Author

von Karsa, L, Patnick, J, Segnan, N, Atkin, W, Halloran, S, Lansdorp-Vogelaar, I, Malila, N, Minozzi, S, Moss, S, Quirke, P, Steele, R J, Vieth, M, Aabakken, L, Altenhofen, L, Ancelle-Park, R, Antoljak, N, Anttila, A, Armaroli, P, Arrossi, S, Austoker, J, Banzi, R, Bellisario, C, Blom, J, Brenner, H, Bretthauer, M, Camargo Cancela, M, Costamagna, G, Cuzick, J, Dai, M, Daniel, J, Dekker, E, Delicata, N, Ducarroz, S, Erfkamp, H, Espinàs, J A, Faivre, J, Faulds Wood, L, Flugelman, A, Frkovic-Grazio, S, Geller, B, Giordano, L, Grazzini, G, Green, J, Hamashima, C, Herrmann, C, Hewitson, P, Hoff, G, Holten, I, Jover, R, Lynge, Elsebeth, von Karsa, L, Patnick, J, Segnan, N, Atkin, W, Halloran, S, Lansdorp-Vogelaar, I, Malila, N, Minozzi, S, Moss, S, Quirke, P, Steele, R J, Vieth, M, Aabakken, L, Altenhofen, L, Ancelle-Park, R, Antoljak, N, Anttila, A, Armaroli, P, Arrossi, S, Austoker, J, Banzi, R, Bellisario, C, Blom, J, Brenner, H, Bretthauer, M, Camargo Cancela, M, Costamagna, G, Cuzick, J, Dai, M, Daniel, J, Dekker, E, Delicata, N, Ducarroz, S, Erfkamp, H, Espinàs, J A, Faivre, J, Faulds Wood, L, Flugelman, A, Frkovic-Grazio, S, Geller, B, Giordano, L, Grazzini, G, Green, J, Hamashima, C, Herrmann, C, Hewitson, P, Hoff, G, Holten, I, Jover, R, and Lynge, Elsebeth

Abstract

Population-based screening for early detection and treatment of colorectal cancer (CRC) and precursor lesions, using evidence-based methods, can be effective in populations with a significant burden of the disease provided the services are of high quality. Multidisciplinary, evidence-based guidelines for quality assurance in CRC screening and diagnosis have been developed by experts in a project co-financed by the European Union. The 450-page guidelines were published in book format by the European Commission in 2010. They include 10 chapters and over 250 recommendations, individually graded according to the strength of the recommendation and the supporting evidence. Adoption of the recommendations can improve and maintain the quality and effectiveness of an entire screening process, including identification and invitation of the target population, diagnosis and management of the disease and appropriate surveillance in people with detected lesions. To make the principles, recommendations and standards in the guidelines known to a wider professional and scientific community and to facilitate their use in the scientific literature, the original content is presented in journal format in an open-access Supplement of Endoscopy. The editors have prepared the present overview to inform readers of the comprehensive scope and content of the guidelines.

Published
2013

74. European guidelines for quality assurance in colorectal cancer screening and diagnosis: overview and introduction to the full supplement publication

Author

Von Karsa, L, Patnick, J, Segnan, N, Atkin, W, Halloran, S, Lansdorp Vogelaar, I, Malila, N, Minozzi, S, Moss, S, Quirke, P, Steele, Rj, Vieth, M, Aabakken, L, Altenhofen, L, Ancelle Park, R, Antoljak, N, Anttila, A, Armaroli, P, Arrossi, S, Austoker, J, Banzi, R, Bellisario, C, Blom, J, Brenner, H, Bretthauer, M, Camargo Cancela, M, Costamagna, Guido, Cuzick, J, Dai, M, Daniel, J, Dekker, E, Delicata, N, Ducarroz, S, Erfkamp, H, Espinàs, Ja, Faivre, J, Faulds Wood, L, Flugelman, A, Frkovic Grazio, S, Geller, B, Giordano, L, Grazzini, G, Green, J, Hamashima, C, Herrmann, C, Hewitson, P, Hoff, G, Holten, I, Jover, R, Kaminski, Mf, Kuipers, Ej, Kurtinaitis, J, Lambert, R, Launoy, G, Lee, W, Leicester, R, Leja, M, Lieberman, D, Lignini, T, Lucas, E, Lynge, E, Mádai, S, Marinho, J, Maučec Zakotnik, J, Minoli, G, Monk, C, Morais, A, Muwonge, R, Nadel, M, Neamtiu, L, Peris Tuser, M, Pignone, M, Pox, C, Primic Zakelj, M, Psaila, J, Rabeneck, L, Ransohoff, D, Rasmussen, M, Regula, J, Ren, J, Rennert, G, Rey, J, Riddell, Rh, Risio, M, Rodrigues, V, Saito, H, Sauvaget, C, Scharpantgen, A, Schmiegel, W, Senore, C, Siddiqi, M, Sighoko, D, Smith, R, Smith, S, Suchanek, S, Suonio, E, Tong, W, Törnberg, S, Villain, P, Van Cutsem, E., Costamagna, Guido (ORCID:0000-0002-8100-2731), Von Karsa, L, Patnick, J, Segnan, N, Atkin, W, Halloran, S, Lansdorp Vogelaar, I, Malila, N, Minozzi, S, Moss, S, Quirke, P, Steele, Rj, Vieth, M, Aabakken, L, Altenhofen, L, Ancelle Park, R, Antoljak, N, Anttila, A, Armaroli, P, Arrossi, S, Austoker, J, Banzi, R, Bellisario, C, Blom, J, Brenner, H, Bretthauer, M, Camargo Cancela, M, Costamagna, Guido, Cuzick, J, Dai, M, Daniel, J, Dekker, E, Delicata, N, Ducarroz, S, Erfkamp, H, Espinàs, Ja, Faivre, J, Faulds Wood, L, Flugelman, A, Frkovic Grazio, S, Geller, B, Giordano, L, Grazzini, G, Green, J, Hamashima, C, Herrmann, C, Hewitson, P, Hoff, G, Holten, I, Jover, R, Kaminski, Mf, Kuipers, Ej, Kurtinaitis, J, Lambert, R, Launoy, G, Lee, W, Leicester, R, Leja, M, Lieberman, D, Lignini, T, Lucas, E, Lynge, E, Mádai, S, Marinho, J, Maučec Zakotnik, J, Minoli, G, Monk, C, Morais, A, Muwonge, R, Nadel, M, Neamtiu, L, Peris Tuser, M, Pignone, M, Pox, C, Primic Zakelj, M, Psaila, J, Rabeneck, L, Ransohoff, D, Rasmussen, M, Regula, J, Ren, J, Rennert, G, Rey, J, Riddell, Rh, Risio, M, Rodrigues, V, Saito, H, Sauvaget, C, Scharpantgen, A, Schmiegel, W, Senore, C, Siddiqi, M, Sighoko, D, Smith, R, Smith, S, Suchanek, S, Suonio, E, Tong, W, Törnberg, S, Villain, P, Van Cutsem, E., and Costamagna, Guido (ORCID:0000-0002-8100-2731)

Abstract

Population-based screening for early detection and treatment of colorectal cancer (CRC) and precursor lesions, using evidence-based methods, can be effective in populations with a significant burden of the disease provided the services are of high quality. Multidisciplinary, evidence-based guidelines for quality assurance in CRC screening and diagnosis have been developed by experts in a project co-financed by the European Union. The 450-page guidelines were published in book format by the European Commission in 2010. They include 10 chapters and over 250 recommendations, individually graded according to the strength of the recommendation and the supporting evidence. Adoption of the recommendations can improve and maintain the quality and effectiveness of an entire screening process, including identification and invitation of the target population, diagnosis and management of the disease and appropriate surveillance in people with detected lesions. To make the principles, recommendations and standards in the guidelines known to a wider professional and scientific community and to facilitate their use in the scientific literature, the original content is presented in journal format in an open-access Supplement of Endoscopy. The editors have prepared the present overview to inform readers of the comprehensive scope and content of the guidelines.

Published
2013

75. European guidelines for quality assurance in colorectal cancer screening and diagnosis: Overview and introduction to the full Supplement publication

Author

Von Karsa, L., Patnick, J., Segnan, N., Atkin, W., Halloran, S., Lansdorp_Vogelaar, Iris, Malila, N., Minozzi, S., Moss, S., Quirke, P., Steele, R., Vieth, M., Aabakken, L., Altenhofen, L., Ancelle-Park, R., Antoljak, N., Anttila, A., Armaroli, P., Arrossi, S., Austoker, J., Banzi, R., Bellisario, C., Blom, J., Brenner, H., Bretthauer, M., Cancela, M., Costamagna, G., Cuzick, J., Dai, M., Daniel, J., Dekker, E., Delicata, N., Ducarroz, S., Erfkamp, H., Espinàs, J., Faivre, J., Wood, L., Flugelman, A., Frkovic-Grazio, S., Geller, B., Giordano, L., Grazzini, G., Green, J., Hamashima, C., Herrmann, C., Hewitson, P., Hoff, G., Holten, I., Jover, R., Kaminski, M., Kuipers, E., Kurtinaitis, J., Lambert, R., Launoy, G., Lee, W., Leicester, R., Leja, M., Lieberman, D., Lignini, T., Lucas, E., Lynge, E., Mádai, S., Marinho, J., Zakotnik, J., Minoli, G., Monk, C., Morais, A., Muwonge, R., Nadel, M., Neamtiu, L., Tuser, M., Pignone, M., Pox, C., Primic-Zakelj, M., Psaila, J., Rabeneck, L., Ransohoff, D., Rasmussen, M., Regula, J., Ren, J., Rennert, G., Rey, J., Riddell, R., Risio, M., Rodrigues, V., Saito, H., Sauvaget, C., Scharpantgen, A., Schmiegel, W., Senore, C., Siddiqi, M., Sighoko, D., Von Karsa, L., Patnick, J., Segnan, N., Atkin, W., Halloran, S., Lansdorp_Vogelaar, Iris, Malila, N., Minozzi, S., Moss, S., Quirke, P., Steele, R., Vieth, M., Aabakken, L., Altenhofen, L., Ancelle-Park, R., Antoljak, N., Anttila, A., Armaroli, P., Arrossi, S., Austoker, J., Banzi, R., Bellisario, C., Blom, J., Brenner, H., Bretthauer, M., Cancela, M., Costamagna, G., Cuzick, J., Dai, M., Daniel, J., Dekker, E., Delicata, N., Ducarroz, S., Erfkamp, H., Espinàs, J., Faivre, J., Wood, L., Flugelman, A., Frkovic-Grazio, S., Geller, B., Giordano, L., Grazzini, G., Green, J., Hamashima, C., Herrmann, C., Hewitson, P., Hoff, G., Holten, I., Jover, R., Kaminski, M., Kuipers, E., Kurtinaitis, J., Lambert, R., Launoy, G., Lee, W., Leicester, R., Leja, M., Lieberman, D., Lignini, T., Lucas, E., Lynge, E., Mádai, S., Marinho, J., Zakotnik, J., Minoli, G., Monk, C., Morais, A., Muwonge, R., Nadel, M., Neamtiu, L., Tuser, M., Pignone, M., Pox, C., Primic-Zakelj, M., Psaila, J., Rabeneck, L., Ransohoff, D., Rasmussen, M., Regula, J., Ren, J., Rennert, G., Rey, J., Riddell, R., Risio, M., Rodrigues, V., Saito, H., Sauvaget, C., Scharpantgen, A., Schmiegel, W., Senore, C., Siddiqi, M., and Sighoko, D.

Abstract

Population-based screening for early detection and treatment of colorectal cancer (CRC) and precursor lesions, using evidence-based methods, can be effective in populations with a significant burden of the disease provided the services are of high quality. Multidisciplinary, evidence-based guidelines for quality assurance in CRC screening and diagnosis have been developed by experts in a project co-financed by the European Union. The 450-page guidelines were published in book format by the European Commission in 2010.They include 10 chapters and over 250 recommendations, individually graded according to the strength of the recommendation and the supporting evidence. Adoption of the recommendations can improve and maintain the quality and effectiveness of an entire screening process, including identification and invitation of the target population, diagnosis and management of the disease and appropriate surveillance in people with detected lesions. To make the principles, recommendations and standards in the guidelines known to a wider professional and scientific community and to facilitate their use in the scientific literature, the original content is presented in journal format in an open-access Supplement of Endoscopy. The editors have prepared the present overview to inform readers of the comprehensive scope and content of the guidelines. © Georg Thieme Verlag KG Stuttgart · New York.

Published
2013

78. Summary of the evidence of breast cancer service screening outcomes in Europe and first estimate of the benefit and harm balance sheet

Author

Ancelle-Park, R., Armaroli, P., Ascunce, N., Bisanti, L., Bellisario, C., Broeders, M., Cogo, C., de Koning, H., Duffy, S. W., Frigerio, A., Giordano, L., Hofvind, S., Jonsson, Håkan, Lynge, E., Massat, N., Miccinesi, G., Moss, S., Naldoni, C., Njor, S., Nyström, Lennarth, Paap, E., Paci, E., Patnick, J., Ponti, A., Puliti, D., Segnan, N., Von Karsa, L., Tornberg, S., Zappa, M., Zorzi, M., Ancelle-Park, R., Armaroli, P., Ascunce, N., Bisanti, L., Bellisario, C., Broeders, M., Cogo, C., de Koning, H., Duffy, S. W., Frigerio, A., Giordano, L., Hofvind, S., Jonsson, Håkan, Lynge, E., Massat, N., Miccinesi, G., Moss, S., Naldoni, C., Njor, S., Nyström, Lennarth, Paap, E., Paci, E., Patnick, J., Ponti, A., Puliti, D., Segnan, N., Von Karsa, L., Tornberg, S., Zappa, M., and Zorzi, M.

Abstract

Objectives To construct a European 'balance sheet' of key outcomes of population-based mammographic breast cancer screening, to inform policy-makers, stakeholders and invited women. Methods From the studies reviewed, the primary benefit of screening, breast cancer mortality reduction, was compared with the main harms, over-diagnosis and false-positive screening results (FPRs). Results Pooled estimates of breast cancer mortality reduction among invited women were 25% in incidence-based mortality studies and 31% in case-control studies (38% and 48% among women actually screened). Estimates of over-diagnosis ranged from 1% to 10% of the expected incidence in the absence of screening. The combined estimate of over-diagnosis for screened women, from European studies correctly adjusted for lead time and underlying trend, was 6.5%. For women undergoing 10 biennial screening tests, the estimated cumulative risk of a FPR followed by non-invasive assessment was 17%, and 3% having an invasive assessment. For every 1000 women screened biennially from age 50-51 until age 68-69 and followed up to age 79, an estimated seven to nine lives are saved, four cases are over-diagnosed, 170 women have at least one recall followed by non-invasive assessment with a negative result and 30 women have at least one recall followed by invasive procedures yielding a negative result. Conclusions The chance of saving a woman's life by population-based mammographic screening of appropriate quality is greater than that of over-diagnosis. Service screening in Europe achieves a mortality benefit at least as great as the randomized controlled trials. These outcomes should be communicated to women offered service screening in Europe.

Published
2012
Full Text
View/download PDF

79. Mammographic screening programmes in Europe:organization, coverage and participation

Author

Giordano, Livia, von Karsa, Lawrence, Tomatis, Mariano, Majek, Ondrej, de Wolf, Chris, Lancucki, Lesz, Hofvind, Solveig, Nyström, Lennarth, Segnan, Nereo, Ponti, Antonio, Van Hal, G, Martens, P, Májek, O, Danes, J, von Euler-Chelpin, My Catarina, Aasmaa, A, Anttila, A, Becker, N, Péntek, Z, Budai, A, Mádai, S, Fitzpatrick, P, Mooney, T, Zappa, M, Ventura, L, Scharpantgen, A, Hofvind, S, Seroczynski, P, Morais, A, Rodrigues, V, Bento, M J, Gomes de Carvalho, J, Natal, C, Prieto, M, Sánchez-Contador Escudero, C, Zubizarreta Alberti, R, Fernández Llanes, S B, Ascunce, N, Ederra Sanza, M, Sarriugarte Irigoien, G, Salas Trejo, D, Ibáñez Cabanell, J, Wiege, M, Ohlsson, G, Törnberg, S, Korzeniewska, M, de Wolf, C, Fracheboud, J, Patnick J, J, Lancucki, L, Giordano, Livia, von Karsa, Lawrence, Tomatis, Mariano, Majek, Ondrej, de Wolf, Chris, Lancucki, Lesz, Hofvind, Solveig, Nyström, Lennarth, Segnan, Nereo, Ponti, Antonio, Van Hal, G, Martens, P, Májek, O, Danes, J, von Euler-Chelpin, My Catarina, Aasmaa, A, Anttila, A, Becker, N, Péntek, Z, Budai, A, Mádai, S, Fitzpatrick, P, Mooney, T, Zappa, M, Ventura, L, Scharpantgen, A, Hofvind, S, Seroczynski, P, Morais, A, Rodrigues, V, Bento, M J, Gomes de Carvalho, J, Natal, C, Prieto, M, Sánchez-Contador Escudero, C, Zubizarreta Alberti, R, Fernández Llanes, S B, Ascunce, N, Ederra Sanza, M, Sarriugarte Irigoien, G, Salas Trejo, D, Ibáñez Cabanell, J, Wiege, M, Ohlsson, G, Törnberg, S, Korzeniewska, M, de Wolf, C, Fracheboud, J, Patnick J, J, and Lancucki, L

Abstract

To summarize participation and coverage rates in population mammographic screening programmes for breast cancer in Europe.

Published
2012

80. False-positive results in mammographic screening for breast cancer in Europe:a literature review and survey of service screening programmes

Author

Hofvind, Solveig, Ponti, Antonio, Patnick, Julietta, Ascunce, Nieves, Njor, Sisse Helle, Broeders, Mireille, Giordano, Livia, Frigerio, Alfonso, Törnberg, Sven, Van Hal, G, Martens, P, Májek, O, Danes, J, von Euler-Chelpin, M, Aasmaa, A, Anttila, A, Becker, N, Péntek, Z, Budai, A, Mádai, S, Fitzpatrick, P, Mooney, T, Zappa, M, Ventura, L, Scharpantgen, A, Hofvind, S, Seroczynski, P, Morais, A, Rodrigues, V, Bento, M J, Gomes de Carvalho, J, Natal, C, Prieto, M, Sánchez-Contador Escudero, C, Zubizarreta Alberti, R, Fernández Llanes, S B, Ascunce, N, Ederra Sanza, M, Sarriugarte Irigoien, G, Salas Trejo, D, Ibáñez Cabanell, J, Wiege, M, Ohlsson, G, Törnberg, S, Korzeniewska, M, de Wolf, C, Fracheboud, J, Patnick, J, Lancucki, L, Ducarroz, S, Hofvind, Solveig, Ponti, Antonio, Patnick, Julietta, Ascunce, Nieves, Njor, Sisse Helle, Broeders, Mireille, Giordano, Livia, Frigerio, Alfonso, Törnberg, Sven, Van Hal, G, Martens, P, Májek, O, Danes, J, von Euler-Chelpin, M, Aasmaa, A, Anttila, A, Becker, N, Péntek, Z, Budai, A, Mádai, S, Fitzpatrick, P, Mooney, T, Zappa, M, Ventura, L, Scharpantgen, A, Hofvind, S, Seroczynski, P, Morais, A, Rodrigues, V, Bento, M J, Gomes de Carvalho, J, Natal, C, Prieto, M, Sánchez-Contador Escudero, C, Zubizarreta Alberti, R, Fernández Llanes, S B, Ascunce, N, Ederra Sanza, M, Sarriugarte Irigoien, G, Salas Trejo, D, Ibáñez Cabanell, J, Wiege, M, Ohlsson, G, Törnberg, S, Korzeniewska, M, de Wolf, C, Fracheboud, J, Patnick, J, Lancucki, L, and Ducarroz, S

Abstract

To estimate the cumulative risk of a false-positive screening result in European mammographic screening programmes, and examine the rates and procedures of further assessment.

Published
2012

81. A fall-off in cervical screening coverage of younger women in developed countries

Author

Lancucki, L, Fender, M, Koukari, A, Lynge, E, Mai, V, Mancini, E, Onysko, J, Ronco, G, Tornberg, S, Vessey, M, Patnick, J, Lancucki, L, Fender, M, Koukari, A, Lynge, E, Mai, V, Mancini, E, Onysko, J, Ronco, G, Tornberg, S, Vessey, M, and Patnick, J

Abstract

Udgivelsesdato: 2010-null, OBJECTIVES: To analyse cervical screening coverage data by age over time in a number of developed countries throughout the world, with specific emphasis on trends for younger women and on age differentials between younger and older women. METHODS: Routinely collected cervical screening statistics and survey data were collected on the proportion of women who have undergone cervical screening with cytology in seven countries in the period 1995 to 2005. RESULTS: Data for the 25-29 age group were examined. Coverage fell in most countries, in three by more than 5 percentage points. In two countries while overall coverage rose in the period, the rise was not as steep in the youngest group of women. Data for each available 5-year age group for the different countries shows a similar gradient in most, regardless of the absolute level of coverage. Although the trend is not uniform in every country, it appears that generally the gap between coverage of younger women and coverage of older women increased, sometimes dramatically, between the mid-1990s and the mid-2000s. CONCLUSIONS: There is a general trend in developed countries towards lower coverage in young women (25-29 years old). No common underlying cause has been clearly identified and there is a need for further studies to investigate the possible reasons for this phenomenon.

Published
2010

82. Reduction in interval cancer rates following the introduction of two-view mammography in the UK breast screening programme

Author

Dibden, A, primary, Offman, J, additional, Parmar, D, additional, Jenkins, J, additional, Slater, J, additional, Binysh, K, additional, McSorley, J, additional, Scorfield, S, additional, Cumming, P, additional, Liao, X-H, additional, Ryan, M, additional, Harker, D, additional, Stevens, G, additional, Rogers, N, additional, Blanks, R, additional, Sellars, S, additional, Patnick, J, additional, and Duffy, S W, additional

Published
2013
Full Text
View/download PDF

83. A randomised trial of weekend and evening breast screening appointments

Author

Offman, J, primary, Wilson, M, additional, Lamont, M, additional, Birke, H, additional, Kutt, E, additional, Marriage, S, additional, Loughrey, Y, additional, Hudson, S, additional, Hartley, A, additional, Smith, J, additional, Eckersley, B, additional, Dungey, F, additional, Parmar, D, additional, Patnick, J, additional, and Duffy, S W, additional

Published
2013
Full Text
View/download PDF

85. Risk of preterm birth following surgical treatment for cervical disease: executive summary of a recent symposium.

Author

Sasieni, P, Castanon, A, Landy, R, Kyrgiou, M, Kitchener, H, Quigley, M, Poon, LCY, Shennan, A, Hollingworth, A, Soutter, WP, Freeman‐Wang, T, Peebles, D, Prendiville, W, Patnick, J, Soutter, W P, and Freeman-Wang, T

Subjects
CERVIX uteri diseases, TREATMENT of cervical intraepithelial neoplasia, PREMATURE labor, LABOR (Obstetrics), DELIVERY (Obstetrics), CONFERENCES & conventions, ELECTROSURGERY, FETAL ultrasonic imaging, GYNECOLOGIC surgery, PREMATURE infants, MEDICAL lasers, PREGNANCY complications, CERVIX uteri tumors, RELATIVE medical risk, CERVICAL intraepithelial neoplasia
Abstract

The article focuses on a symposium on the association between surgical treatment of cervical intraepithelial neoplasia (CIN) and subsequent preterm birth held on February 16, 2015 in London, Great Britain. It is stated that CIN grades 2 and 3 that have been managed surgically were the main focus of the meeting.

Published
2016
Full Text
View/download PDF

95. A retrospective observational study examining the characteristics and outcomes of tumours diagnosed within and without of the English NHS Bowel Cancer Screening Programme

Author

Morris, E J A, primary, Whitehouse, L E, additional, Farrell, T, additional, Nickerson, C, additional, Thomas, J D, additional, Quirke, P, additional, Rutter, M D, additional, Rees, C, additional, Finan, P J, additional, Wilkinson, J R, additional, and Patnick, J, additional

Published
2012
Full Text
View/download PDF

96. Are women ready for the new cervical screening protocol in England? A systematic review and qualitative synthesis of views about human papillomavirus testing

Author

Hendry, M, primary, Pasterfield, D, additional, Lewis, R, additional, Clements, A, additional, Damery, S, additional, Neal, R D, additional, Adke, R, additional, Weller, D, additional, Campbell, C, additional, Patnick, J, additional, Sasieni, P, additional, Hurt, C, additional, Wilson, S, additional, and Wilkinson, C, additional

Published
2012
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results